Rolf Grempler

Rolf Grempler is an experienced clinical pharmacologist with a significant tenure at Boehringer Ingelheim from February 2017 to August 2024, where responsibilities included leadership roles as Principal Clinical Pharmacology Lead and Director Clinical Pharmacology Lead, focusing on clinical pharmacology, drug-drug interactions, and pharmaceutical submissions. Prior to this, Rolf held the position of Project Pharmacokineticist/Clinical Pharmacology Integrator, concentrating on the integration of clinical pharmacology in oncology projects. Earlier academic experience includes a role as a Postdoctoral Research Fellow at Ernst-Moritz Arndt University, engaged in preclinical diabetes research using adenovirus-mediated gene transfer and teaching biochemistry to medical students. Rolf holds a Ph.D. in Biochemistry and a Master's degree in Human Biology, both obtained from Universität Greifswald.